Export

Ombitasvir + paritaprevir + ritonavir
Essential medicine status
General description

INN
Ombitasvir + paritaprevir + ritonavir
Medicine type
Chemical agent
EML status history
First added in 2015 (TRS 994) for Chronic hepatitis C
Therapeutic equivalent for
Recommendations
Section
Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
  • Oral > Solid: 12.5 mg + 75 mg + 50 mg tablet